Genesco QTD total sales up 18% YoY; reaffirms FY22 EPS guidance at $6.40-$6.90, expecting above midpoint

GENESCO INC

Total overall sales for the 8 weeks ended Dec 25, 2021 increased 18% vs FY21 and 9% vs FY20.
Journeys +8%, Schuh +28%, Johnston & Murphy +53%, Licensed Brands +104% vs FY21.
CEO cites strong full-price holiday selling despite supply chain challenges; January trend moderated due to lean inventory.
Reaffirms FY22 EPS guidance of $6.40-$6.90, with expectation now above midpoint; adjusted EPS above midpoint expected.
Direct sales fell 10% vs FY21 but rose 33% vs FY20; store sales up 18% vs FY21, down 2% vs FY20.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.